94 related articles for article (PubMed ID: 20961889)
1. Screening for renal cancer in recipients of kidney transplants.
Wong G; Howard K; Webster AC; Chapman JR; Craig JC
Nephrol Dial Transplant; 2011 May; 26(5):1729-39. PubMed ID: 20961889
[TBL] [Abstract][Full Text] [Related]
2. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
Wong G; Howard K; Webster A; Chapman JR; Craig JC
Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
[TBL] [Abstract][Full Text] [Related]
3. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of colorectal cancer screening in renal transplant recipients.
Wong G; Howard K; Craig JC; Chapman JR
Transplantation; 2008 Feb; 85(4):532-41. PubMed ID: 18347531
[TBL] [Abstract][Full Text] [Related]
5. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
6. The routine use of high-resolution immunological screening of recipients of primary deceased donor kidney allografts is cost-effective.
McLaughlin K; Manns B; Nickerson P
Transplantation; 2006 May; 81(9):1278-84. PubMed ID: 16699455
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
9. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
[TBL] [Abstract][Full Text] [Related]
10. The uptake of cervical cancer screening by renal transplant recipients.
Courtney AE; Leonard N; O'Neill CJ; McNamee PT; Maxwell AP
Nephrol Dial Transplant; 2009 Feb; 24(2):647-52. PubMed ID: 18952575
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
12. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
14. A third kidney transplant: cost-effective treatment for end-stage renal disease?
Matas AJ; Gillingham KJ; Payne WD; Dunn DL; Gruessner RW; Sutherland DE; Schmidt W; Najarian JS
Clin Transplant; 1996 Dec; 10(6 Pt 1):516-20. PubMed ID: 8996772
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of cancer screening in end-stage renal disease.
Chertow GM; Paltiel AD; Owen WF; Lazarus JM
Arch Intern Med; 1996 Jun; 156(12):1345-50. PubMed ID: 8651845
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
[TBL] [Abstract][Full Text] [Related]
18. The pattern of excess cancer in dialysis and transplantation.
Stewart JH; Vajdic CM; van Leeuwen MT; Amin J; Webster AC; Chapman JR; McDonald SP; Grulich AE; McCredie MR
Nephrol Dial Transplant; 2009 Oct; 24(10):3225-31. PubMed ID: 19589786
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
20. Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer.
Ehdaie B; Stukenborg GJ; Theodorescu D
J Urol; 2009 Oct; 182(4):1482-7. PubMed ID: 19683766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
